MD - Company ID 0000893949
The table below shows Pediatrix Medical Group, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$129.85M | -$117.46M | -$125.23M | -$100.92M | -$97.48M | -$82.19M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$11.98M | -$7.46M | -$16.24M | -$11.35M | -$26.27M | -$10.36M |
| Dividends paid | - | - | - |
Pediatrix Medical Group, Inc. reported operating cash flow of $271.09M for fiscal year 2025. That is up 31.2% from $206.57M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $443.78M (FY 2016) to $271.09M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | $21.45M | $1.57M | $887.00K | $775.00K | $1.17M | $1.99M |
| Financing cash flow | -$27.64M | -$6.04M | $76.20M | $108.57M | -$256.46M | -$761.66M |